About this Event
Turning advanced science into a successful clinical programme requires more than innovation alone. The decisions made early—from CMC strategy and manufacturing to regulatory planning and investment readiness—can shape development timelines and influence long-term success.
Hosted by Thermo Fisher Scientific in association with the BioIndustry Association (BIA), Biotech Horizons - London 2026 brings together biotech founders, industry leaders, investors, and subject matter specialists to share practical strategies for preparing innovative therapies for the clinic.
What you'll gain
- Practical guidance to building an effective early-stage CMC strategy
- Specialist advice on preparing for IND and clinical readiness
- Lessons on avoiding common manufacturing and regulatory challenges
- Perspectives from investors on what strengthens development programmes
- Real-world experiences from biotech leaders who have navigated the journey to the clinic
- Opportunities to connect with peers across the biotech ecosystem
PLEASE NOTE: We are now nearing capacity for our event due to a fantastic response. To help ensure the event is attended by the intended audience, registrations will be reviewed and prioritised accordingly. We will therefore be unable to automatically approve all registrations. We’ll be in touch to confirm your place once your registration has been approved.
Thank you for your interest and understanding.
Date: 21 October 2026
Location: London Victoria House, 37-63 Southampton Row, London WC1B 4DR
Lunch Included
Agenda
🕑: 09:00 AM - 09:30 AM
Arrival, refreshments and registration
Info: Council chamber, 3rd floor
Welcome and introduction
Host: Giovanni Lorenzon, Thermo Fisher Scientic
🕑: 09:45 AM - 10:15 AM
Why CMC matters from day one
Host: Giovanni Lorenzon, Manager, Thermo Fisher Scientific
🕑: 10:15 AM - 10:45 AM
Building the right CMC strategy: Early development decisions
Host: Mike Brewer, Regulatory, Thermo Fisher Scientific
🕑: 10:45 AM - 11:15 AM
Coffee break and live polling
Info: Council chamber, 3rd floor
🕑: 11:15 AM - 12:15 PM
Panel discussion: Does CMC really deserve a seat at the executive table?
Host: Richard Dennett, Thermo Fisher Scientific
🕑: 12:15 PM - 01:15 PM
Networking lunch
Info: Exhibition area, 3rd floor
🕑: 01:15 PM - 02:00 PM
Founder case study: Lessons from the biotech journey
Host: Dave Simpson, CEO, Iksuda Therapeutics
🕑: 02:00 PM - 02:30 PM
Critical considerations for accelerating the path to the clinic
Host: Mike Brewer, Regulatory, Thermo Fisher Scientific
🕑: 02:30 PM - 03:00 PM
Refreshment break
Info: Council chamber, 3rd floor
The last mile before the clinic: Avoiding drug product and fill-finish delays
Host: Alessandro Chreim, Patheon Services Group Thermo Fisher
🕑: 03:30 PM - 04:00 PM
Investor perspective: What are good CMC signals to investors
Host: Tim Haines, Managing Director, Abingworth
🕑: 04:00 PM - 04:30 PM
Q&A session
🕑: 04:30 PM - 04:40 PM
Wrap up and closing remarks
Host: Giovanni Lorenzon, Thermo Fisher Scientific
🕑: 04:40 PM - 06:00 PM
Drinks, networking & lab tours
Info: Networking: Ground Central Hall
Lab tour: 8th floor
Event venue & nearby stays
Victoria House, 37-63 Southampton Row, London, United Kingdom
Concerts, fests, parties, meetups — all the happenings, one place.